Kazia Therapeutics (KZIA) Current Assets (2017 - 2025)

Kazia Therapeutics' Current Assets history spans 6 years, with the latest figure at $3.2 million for Q2 2025.

  • For Q2 2025, Current Assets fell 21.97% year-over-year to $3.2 million; the TTM value through Jun 2025 reached $3.2 million, down 21.97%, while the annual FY2025 figure was $3.2 million, 21.97% down from the prior year.
  • Current Assets reached $3.2 million in Q2 2025 per KZIA's latest filing, down from $4.0 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $7.2 million in Q2 2023 to a low of $3.2 million in Q2 2025.
  • Average Current Assets over 4 years is $5.3 million, with a median of $5.4 million recorded in 2022.
  • Peak YoY movement for Current Assets: grew 6.38% in 2023, then plummeted 43.75% in 2024.
  • A 4-year view of Current Assets shows it stood at $6.8 million in 2022, then grew by 6.38% to $7.2 million in 2023, then crashed by 43.75% to $4.0 million in 2024, then dropped by 21.97% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Current Assets are $3.2 million (Q2 2025), $4.0 million (Q2 2024), and $7.2 million (Q2 2023).